* Metacrine Inc MTCR.OQ reported a quarterly adjusted loss
of 15
cents per share for the quarter ended in June. The mean
expectation of two analysts for the quarter was for a loss of 25
cents per share.
* Reported revenue was zero; analysts expected zero.
* Metacrine Inc's reported EPS for the quarter was a loss
of 15
cents.
* The mean earnings estimate of analysts had risen by
about 33.3%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Metacrine Inc shares had fallen by 2.0% this quarter and
lost 27.3% so far this year.
* The company reported a quarterly loss of $6.26 million.
* Wall Street's median 12-month price target for Metacrine
Inc is
$0.50
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data August 10
at 09:05 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2022 -0.25 -0.15 Beat
Mar. 31 2022 -0.39 -0.31 Beat
Dec. 31 2021 -0.63 -0.32 Beat
Sep. 30 2021 -0.61 -0.69 Missed